Gilead Sciences
GILD
GILD
1,764 hedge funds and large institutions have $88.9B invested in Gilead Sciences in 2022 Q4 according to their latest regulatory filings, with 290 funds opening new positions, 560 increasing their positions, 735 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.69% more ownership
Funds ownership: 80.38% → 82.07% (+1.7%)
3% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.27B
24% less repeat investments, than reductions
Existing positions increased: 560 | Existing positions reduced: 735
Holders
1,764
Holding in Top 10
64
Calls
$1.24B
Puts
$1.27B
Top Buyers
| 1 | +$1.07B | |
| 2 | +$881M | |
| 3 | +$328M | |
| 4 |
BlackRock
New York
|
+$245M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$214M |
Top Sellers
| 1 | -$303M | |
| 2 | -$176M | |
| 3 | -$147M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$138M |
| 5 |
VanEck Associates
New York
|
-$133M |